These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Famotidine in the USA: a review of efficacy studies. Gitnick G J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage]. Vasil'ev IuV; Li IA Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271 [TBL] [Abstract][Full Text] [Related]
6. Omeprazole: a comprehensive review. Massoomi F; Savage J; Destache CJ Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967 [TBL] [Abstract][Full Text] [Related]
7. [Drug therapy of ulcer and reflux esophagitis. Recommendations from a group of experts]. Lakartidningen; 1993 Jul; 90(28-29):2530-2. PubMed ID: 8326797 [No Abstract] [Full Text] [Related]
8. Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide. Reynolds JC Clin Ther; 1988; 10(4):436-49. PubMed ID: 3079011 [TBL] [Abstract][Full Text] [Related]
9. [Study on the efficacy of famotidine (Quamatel) in the complex treatment of erosive gastroduodenitis, stress stomach ulcer and peptic duodenal ulcer]. Korukov B; Ognianov S; Kostadinova R; Gerzilov P; Ivanov A; Iarŭmov N Khirurgiia (Sofiia); 2004; 60(1):4-7. PubMed ID: 15704743 [TBL] [Abstract][Full Text] [Related]
11. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer]. Pal'tsev AI; Maslennikova TA Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582 [No Abstract] [Full Text] [Related]
12. The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers. Watanabe Y; Tsumura H; Sasaki H; Morimoto T Clin Ther; 1990; 12(6):534-46. PubMed ID: 2289221 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacotherapy of non-associated with Helicobacter pylori ulcer]. Grinevich VB; Uspenskiĭ IuP; Shabanova GZh; Sablin OA; Shcherbina NN Klin Med (Mosk); 2002; 80(10):44-6. PubMed ID: 12471838 [TBL] [Abstract][Full Text] [Related]
14. [Is famotidine--the 3d generation H2 receptor antagonist--a step in progress in the treatment of duodenal ulcer?]. Stasiewicz J; Romatowski J; Kluz A; Szałaj W; Namiot Z Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1684-6. PubMed ID: 3077455 [No Abstract] [Full Text] [Related]
15. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer]. Maculotti L; Pradella P Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265 [TBL] [Abstract][Full Text] [Related]
16. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology. Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885 [TBL] [Abstract][Full Text] [Related]
17. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis. Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110 [TBL] [Abstract][Full Text] [Related]
18. Famotidine in the short and long-term treatment of duodenal ulcer. Zaterka S; de Paula Castro L; Villalobos JJ; Massuda HK; Eisig JN; Dias Avelar C; Coelho LG; Bettarello A Acta Gastroenterol Latinoam; 1988; 18(2):115-21. PubMed ID: 3075106 [TBL] [Abstract][Full Text] [Related]